Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Chorionic Gonadotropin Market Growth Potential: How Will Market Size Shift Through 2030?
The chorionic gonadotropin market has demonstrated strong growth over the past few years. It is anticipated to increase from $1.34 million in 2025 to $1.43 million in 2026, exhibiting a compound annual growth rate (CAGR) of 6.5%. The historical expansion of this market is attributable to the growth of infertility treatments, its established function in ovulation induction, a rise in male reproductive disorders, the availability of hospital-based fertility programs, and its enduring clinical application.
The chorionic gonadotropin market size is anticipated to undergo significant growth in the upcoming years. It is expected to reach $1.82 million by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This expansion during the forecast period can be attributed to factors such as rising global infertility rates, the increasing prevalence of assisted reproductive technologies, greater awareness of male hormonal disorders, expanded applications in oncology diagnostics, and improved availability through retail pharmacies. Notable trends for the forecast period include its growing utilization in assisted reproductive treatments, an increase in its application for male hypogonadism therapy, a heightened demand for fertility hormone therapies, its expanded diagnostic use as a tumor marker, and advancements in its formulations and dosage accuracy.
Get A Free Sample Report With In-Depth Market Insights:
Chorionic Gonadotropin Market Growth Momentum: What Factors Are Shaping Demand?
The chorionic gonadotropin market is projected to expand due to the increasing incidence of infertility issues. Infertility is defined as the inability to conceive a child after one year of regular, unprotected sexual intercourse for couples under 35 years of age, or after six months for couples 35 years and older. The rising occurrence of infertility primarily stems from delayed childbearing, as many individuals opt to have children later in life, alongside lifestyle factors such as obesity and smoking, which can adversely affect reproductive health. Chorionic Gonadotropin (hCG) finds application in fertility treatments to induce ovulation in women, support the luteal phase for pregnancy maintenance, and stimulate testosterone production in men to enhance sperm count, thereby addressing various infertility challenges. For instance, in April 2023, the World Health Organization (WHO), a Switzerland-based specialized agency, reported that approximately 17.5% of the adult population, or 1 in 6 people worldwide, encounter infertility, emphasizing the urgent necessity for improved access to affordable, high-quality fertility care for those affected. Therefore, the growing prevalence of infertility issues is propelling the growth of the chorionic gonadotropin market.
Chorionic Gonadotropin Market Segment Breakdown: Which Categories Lead On Revenue?
The chorionic gonadotropin market covered in this report is segmented –
1) By Type: Human Chorionic Gonadotropin, Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain, Other Therapeutic Applications
4) By End User: Research Institutions, Pharmaceutical Companies
Chorionic Gonadotropin Market Trends Redefining Industry Growth
Companies actively involved in the chorionic gonadotropin market are prioritizing the development of advanced solutions, such as saliva-based pregnancy tests, to boost convenience, accuracy, and accessibility. A saliva-based pregnancy test is defined as a non-invasive diagnostic technique that identifies pregnancy by analyzing human chorionic gonadotropin (hCG), a hormone produced during pregnancy, within a woman’s saliva. For instance, in June 2023, Salignostics, an Israel-based biotech company, launched the world’s first saliva-based pregnancy test. This innovative product enables women to determine pregnancy using a saliva sample instead of urine, detecting the hCG hormone with results available within just 5 to 15 minutes. Salistick offers a more comfortable and practical testing experience, allowing users to test anywhere and share the occasion with partners or loved ones.
Chorionic Gonadotropin Market Leading Players And Competitive Positioning
Major companies operating in the chorionic gonadotropin market are Ferring Pharmaceuticals
View The Full Chorionic Gonadotropin Market Report:
Chorionic Gonadotropin Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
